US2020402643A1
|
|
Cognitive screens, monitor and cognitive treatments targeting immune-mediated and neuro-degenerative disorders
|
WO2020097626A1
|
|
Facial expression detection for screening and treatment of affective disorders
|
US10593221B1
|
|
Audio-only interference training for cognitive disorder screening and treatment
|
WO2020081617A1
|
|
Cognitive platform for deriving effort metric for optimizing cognitive treatment
|
TW201944429A
|
|
Cognitive screens, monitor and cognitive treatments targeting immune-mediated and neuro-degenerative disorders
|
WO2019161050A1
|
|
Cognitive platform including computerized elements coupled with a therapy for mood disorder
|
EP3669343A1
|
|
Cognitive platform including computerized elements
|
WO2019028376A1
|
|
Cognitive platform including computerized evocative elements in modes
|
WO2018222729A1
|
|
Platform for identification of biomarkers using navigation tasks and treatments based thereon
|
CN110637342A
|
|
Distributed network for secure collection, analysis and sharing of data across platforms
|
WO2018132483A1
|
|
Cognitive platform configured for determining the presence or likelihood of onset of a neuropsychological deficit or disorder
|
US2019343447A1
|
|
Platform for identification of biomarkers using navigation tasks and treatments using navigation tasks
|
CA3041648A1
|
|
Cognitive platform configured as a biomarker or other type of marker
|
EP3503809A1
|
|
Cognitive platform coupled with a physiological component
|
US2019159716A1
|
|
Cognitive platform including computerized evocative elements
|
CN109996485A
|
|
The platform of signal detection measurement is realized during adaptive reaction-deadline
|
US2019261908A1
|
|
Platforms to implement signal detection metrics in adaptive response-deadline procedures
|
US2016262680A1
|
|
Processor Implemented Systems and Methods for Measuring Cognitive Abilities
|
KR20170007431A
|
|
Processor-implemented systems and methods for enhancing cognitive abilities by personalizing cognitive training regimens
|